GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
A leader in plasma-derived products, today announced the presentation of new research evaluating the aggregation profiles, including molecular size distribution and particle size, in commercially available intravenous immunoglobulin (IVIG)...

